CTT, Gelatinase Inhibitor, is a synthetic peptide designed to bind matrix metalloproteinases and modulate extracellular matrix turnover. Its sequence supports analysis of substrate-recognition motifs and inhibitory frameworks. Researchers explore its conformation to evaluate enzyme-ligand docking. The peptide aids studies of protease regulation mechanisms.
CAT No: C08080
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More